The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol DOI
Julie A. Womack,

Micaela M. Leblanc,

Annette S. Sager

и другие.

AIDS and Behavior, Год журнала: 2024, Номер unknown

Опубликована: Окт. 28, 2024

Язык: Английский

Clinical characteristics and risk factors of osteoporosis among older Asian men with type-2 diabetes mellitus, hypertension, or hyperlipidaemia DOI Creative Commons
Yu Quan Tan, Ding Xuan Ng,

Kalaipriya Gunasekaran

и другие.

Archives of Osteoporosis, Год журнала: 2024, Номер 19(1)

Опубликована: Сен. 5, 2024

Язык: Английский

Процитировано

2

A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases DOI Creative Commons
Marie‐Eve Gagnon, Miceline Mésidor, Marc Simard

и другие.

Research in Social and Administrative Pharmacy, Год журнала: 2024, Номер 20(9), С. 905 - 910

Опубликована: Май 23, 2024

The variety of methods for counting medications may lead to confusion when attempting compare the extent polypharmacy across different populations.

Язык: Английский

Процитировано

1

Association Between the Use of Orexin Receptor Antagonists and Falls or Fractures: A Meta-Analysis DOI

Guobiao Pan,

Lingzhi Ni,

Haohao Yan

и другие.

Journal of Psychiatric Research, Год журнала: 2024, Номер 176, С. 393 - 402

Опубликована: Июнь 25, 2024

Язык: Английский

Процитировано

0

Association between Polypharmacy and Adverse Events in Patients with Alzheimer’s Disease: An Analysis of the Japanese Adverse Drug Event Report Database (JADER) DOI Creative Commons

Nobuhiro Otani,

Kanae Kanda, Nlandu Roger Ngatu

и другие.

Medicina, Год журнала: 2024, Номер 60(10), С. 1633 - 1633

Опубликована: Окт. 6, 2024

: Alzheimer's disease is a global health concern, with rising prevalence among the elderly. Current pharmacological treatments, including acetylcholinesterase inhibitors (AChEIs) and N-Methyl D-Aspartate (NMDA) receptor antagonists, are associated adverse events (AEs), particularly in context of polypharmacy. This study aimed to investigate relationship between treatment combinations, number concomitant medications, occurrence AEs.

Язык: Английский

Процитировано

0

The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol DOI
Julie A. Womack,

Micaela M. Leblanc,

Annette S. Sager

и другие.

AIDS and Behavior, Год журнала: 2024, Номер unknown

Опубликована: Окт. 28, 2024

Язык: Английский

Процитировано

0